Viral Hepatitis at AASLD 2022: Practice-Changing Data
Practice-Changing Viral Hepatitis Data From AASLD 2022

Released: December 06, 2022

Nancy Reau
Nancy Reau, MD

Activity

Progress
1
Course Completed

In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including:

  • Novel therapeutics for HBV
  • HCV management strategies
  • HDV screening and linkage to care
  • Fatty liver disease in persons with viral hepatitis
  • Use of statins to decrease morbidity and mortality in persons with liver disease